Orchestra BioMed Holdings (OBIO) Earnings Date & Reports
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
OBIO is expected to report earnings to rise 21.39% to -40 cents per share on November 16
Q3'26
Est.
$-0.40
Q1'26
Beat
by $0.19
Q4'25
Beat
by $0.56
Q3'25
Beat
by $0.06
Q2'25
Missed
by $0.04
The last earnings report on May 12 showed earnings per share of -33 cents, beating the estimate of -51 cents. With 277.43K shares outstanding, the current market capitalization sits at 305.33M.